منابع مشابه
Voice Disorders in Mucosal Leishmaniasis
INTRODUCTION Leishmaniasis is considered as one of the six most important infectious diseases because of its high detection coefficient and ability to produce deformities. In most cases, mucosal leishmaniasis (ML) occurs as a consequence of cutaneous leishmaniasis. If left untreated, mucosal lesions can leave sequelae, interfering in the swallowing, breathing, voice and speech processes and req...
متن کاملOtolaryngologic Presentation of Mucosal Leishmaniasis
Mucosal leishmaniasis (ML) is an uncommon complication of a disease seen primarily in the developing world. A 31-year-old previously healthy man presented with six months of nasal congestion, throat pain, hoarseness, and intermittent dysphagia and odynophagia. The leishmania culture was positive, and PCR testing was consistent with Leishmania braziliensis infection. He was treated with liposoma...
متن کاملDiagnostic dilemma of primary mucosal leishmaniasis.
Leishmaniasis is caused by Leishmania protozoa. It is widely present in more than 88 countries worldwide, resulting in up to 80,000 deaths annually. Leishmaniasis occurs as visceral, cutaneous, or mucocutaneous variants. Mucosal involvement can occur secondarily to the cutaneous or visceral varieties. However, primary mucosal leishmaniasis (PML) occurs without any present or past cutaneous and ...
متن کاملTreatment of Bolivian mucosal leishmaniasis with miltefosine.
BACKGROUND Although mucosal leishmaniasis is a prominent disease, it has been studied only to a limited extent. It is classically treated with parenteral antimony or, as a last resort, amphotericin B. METHODS We treated Bolivian mucosal leishmaniasis due to Leishmania braziliensis with the oral agent miltefosine, 2.5 mg/kg/day for 28 days, and followed-up for 12 months. RESULTS Seventy-two ...
متن کاملMucosal leishmaniasis: epidemiological and clinical aspects.
UNLABELLED Leishmaniasis has been documented in several countries, with an estimated prevalence of 12 million people and an incidence at around 400,000 new cases per year. Leishmaniasis in the New World is one the major endemic diseases in Brazil and Latin America. OBJECTIVE The aim of this study was to add to the current knowledge on mucosal leishmaniasis, bringing the experience of the Immu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Revista da Sociedade Brasileira de Medicina Tropical
سال: 2003
ISSN: 0037-8682
DOI: 10.1590/s0037-86822003000200017